Clinical Trial Update: Vitamin D as a Key Player in Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating vitamin D as a key modulator in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Vitamin D (Cholecalciferol)

Snippet

Sponsor: Assiut University | Conditions: the Immunomodulatory Effect | Phase 3 | Status: COMPLETED